THYMIDINE LABELING INDEX AS PROGNOSTIC FACTOR IN RESECTED NON-SMALL CELL LUNG-CANCER

被引：27

作者：

ALAMA, A ^{[1
]}

COSTANTINI, M ^{[1
]}

REPETTO, L ^{[1
]}

CONTE, PF ^{[1
]}

SERRANO, J ^{[1
]}

NICOLIN, A ^{[1
]}

BARBIERI, F ^{[1
]}

ARDIZZONI, A ^{[1
]}

BRUZZI, P ^{[1
]}

机构：

[1] OSPED SAN MARTINO GENOVA,GENOA,ITALY

来源：

EUROPEAN JOURNAL OF CANCER | 1990年 / 26卷 / 05期

关键词：

D O I：

10.1016/0277-5379(90)90093-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

To assess the prognostic value of tumor proliferative activity, 89 patients with operable non-small cell lung cancer were studied. Tumor samples were obtained during surgery and cell kinetics were analyzed by the in vitro thymidine labelling index (TLI). The overall median TLI (2.9) was used to identify two subsets of patients with high and low proliferating tumors. In univariate analysis survival was significantly longer in patients with lower TLI (P = 0.047) and with stage I-II (P = 0.003) and T1-T2 tumors (P = 0.043). In multivariate analysis, stage was the most important prognostic parameter (P = 0.004). The risk of death for patients with TLI higher than 2.9 was increased (hazard ratio = 2.01, CI = 0.96-4.27). © 1990.

引用

页码：622 / 625

页数：4

共 50 条

[31] Surveillance of resected non-small cell lung cancer
A. López-González
P. Ibeas Millán
B. Cantos
M. Provencio
Clinical and Translational Oncology, 2012, 14 : 721 - 725
[32] Surveillance of resected non-small cell lung cancer
Lopez-Gonzalez, A.
Ibeas Millan, P.
Cantos, B.
Provencio, M.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (10): : 721 - 725
[33] PROGNOSTIC-SIGNIFICANCE OF NEUROENDOCRINE DIFFERENTIATION IN NON-SMALL CELL LUNG-CANCER
SUNDARESAN, V
REEVE, JG
STEWART, S
BLEEHEN, NM
JOURNAL OF PATHOLOGY, 1990, 160 (02): : A153 - A153
[34] pERK as a new prognostic factor in resected, early-staged, non-small cell lung cancer (NSCLC)
Dolores Mediano, Maria
Corral Jaime, Jesus
Molina-Pinelo, Sonia
Alonso, Miriam
Ferrer, Irene
Atienza, Maria
Moreno, Nicolas
Carnero Moya, Amancio
Paz-Ares, Luis
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[35] The Prognostic Impact of Pericardial Fat Volumes in Resected Non-small Cell Lung Cancer
Shuichi Shinohara
Ryo Otsuki
Kenichi Kobayashi
Masaki Matsuo
Ken Harada
Masakazu Sugaya
Makoto Nakagawa
Annals of Surgical Oncology, 2020, 27 : 481 - 489
[36] Tumor Engraftment is Prognostic for Disease Recurrence in Resected Non-Small Cell Lung Cancer
Patel, B. G.
Pepin, K.
Li, S.
Davies, S. R.
Rohatgi, A.
Herzog, B.
Ward, J. P.
Baggstrom, M.
Waqar, S.
Morgensztern, D.
Govindan, R.
Devarakonda, S.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E22 - E22
[37] The Prognostic Factors of Resected Non-Small Cell Lung Cancer with Chest Wall Invasion
Lee, Chang Young
Lee, Jin Gu
Park, In Kyu
Kim, Dae Joon
Chung, Kyung Young
JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S412 - S412
[38] Prognostic factors before and after recurrence of resected non-small cell lung cancer
Baba, Tetsuro
Uramoto, Hidetaka
Takenaka, Masaru
Chikaishi, Yasuhiro
Oka, Soichi
Shigematsu, Yoshiki
Hanagiri, Takeshi
Tanaka, Fumihiro
RESPIRATORY INVESTIGATION, 2012, 50 (04) : 151 - 156
[39] Prognostic implications of cellular senescence in resected non-small cell lung cancer br
Domen, Andreas
Deben, Christophe
De Pauw, Ines
Hermans, Christophe
Lambrechts, Hilde
Verswyvel, Jasper
Siozopoulou, Vasiliki
Pauwels, Patrick
Demaria, Marco
van de Wiel, Mick
Janssens, Annelies
Hendriks, Jeroen M. H.
Van Schil, Paul
Vermorken, Jan B.
Vandamme, Timon
Prenen, Hans
Peeters, Marc
Lardon, Filip
Wouters, An
TRANSLATIONAL LUNG CANCER RESEARCH, 2022, : 1526 - 1539
[40] DNA ploidy as a prognostic marker in completely resected non-small cell lung cancer
Mugüerza, JM
Asenjo, JAL
Díez, M
Gómez, A
Torres, A
Granell, J
Noguerales, F
Balibrea, JL
BRITISH JOURNAL OF SURGERY, 1998, 85 : 99 - 99

← 1 2 3 4 5 →